Business Combinations (Tables)

6 Months Ended

Jul. 03, 2022

Business Acquisition [Line Items]

Business Acquisition, Pro Forma Information [Table Text Block]

The following unaudited pro forma information presents the combined financial results for the Company and BioLegend as if the acquisition of BioLegend had been completed at the beginning of fiscal year 2020:

	Three Months Ended July 4, 2021		Six Months Ended July 4, 2021
	(In thousands, except per share data)
Pro Forma Statement of Operations Information:
Revenue	$	1,310,191	$	2,695,305
Income from continuing operations	239,940		607,074
Basic earnings per share:
Income from continuing operations	$	1.90	$	4.82
Diluted earnings per share:
Income from continuing operations	$	1.90	$	4.80